Nucleome Therapeutics Company
![](/storage/logos_100px/Nucleome Therapeutics.jpeg)
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Technology:
Data-driven Technologies
Industry:
Gene therapy
Headquarters:
Headington, Oxfordshire, United Kingdom
Founded Date:
2019
Employees Number:
1-10
Funding Status:
Seed
Register and Claim Ownership